Midazolam Oxidation by Cytochrome P450 3A4 and Active-Site Mutants: an Evaluation of Multiple Binding Sites and of the Metabolic Pathway That Leads to Enzyme Inactivation
- 1 March 2002
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 61 (3) , 495-506
- https://doi.org/10.1124/mol.61.3.495
Abstract
Midazolam (MDZ) oxidation by recombinant CYP3A4 purified fromEscherichia coli and 30 mutants generated at 15 different substrate recognition site positions has been studied to determine the role of individual residues in regioselectivity and to investigate the possible existence of multiple binding sites. Initial results showed that oxidation of MDZ by CYP3A4 causes time- and concentration-dependent enzyme inactivation withKI and kinactvalues of 5.8 μM and 0.15 min−1, respectively. The different time courses of MDZ hydroxylation by mutants that predominantly formed 1′-OH MDZ as opposed to 4-OH MDZ provided strong evidence that the 1′-OH MDZ pathway leads to CYP3A4 inactivation. Correlational analysis of 1′-OH formation versus 4-OH formation by the mutants supports the inference that the two metabolites result from the binding of MDZ at two separate sites. Thus, substitution of residues Phe-108, Ile-120, Ile-301, Phe-304, and Thr-309 with a larger amino acid caused an increase in the ratio of 1′-OH/4-OH MDZ formation, whereas substitution of residues Ser-119, Ile-120, Leu-210, Phe-304, Ala-305, Tyr-307, and Thr-309 with a smaller amino acid decreased this ratio. Kinetic analyses of nine key mutants revealed that the alteration in regioselectivity is caused by a change in kinetic parameters (Vmax andKM) for the formation of both metabolites in most cases. The study revealed the role of various active-site residues in the regioselectivity of MDZ oxidation, identified the metabolic pathway that leads to enzyme inactivation, and provided an indication that the two proposed MDZ binding sites in CYP3A4 may be partially overlapping.Keywords
This publication has 30 references indexed in Scilit:
- Covalent Alteration of the CYP3A4 Active Site: Evidence for Multiple Substrate Binding DomainsArchives of Biochemistry and Biophysics, 2001
- A Kinetic Model for the Metabolic Interaction of Two Substrates at the Active Site of Cytochrome P450 3A4Published by Elsevier ,2001
- Elucidation of Distinct Ligand Binding Sites for Cytochrome P450 3A4Biochemistry, 2000
- Structure−Function Relationships of Human Liver Cytochromes P450 3A: Aflatoxin B1 Metabolism as a ProbeBiochemistry, 1998
- IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3AAnnual Review of Pharmacology and Toxicology, 1998
- Identification of Three Key Residues in Substrate Recognition Site 5 of Human Cytochrome P450 3A4 by Cassette and Site-Directed MutagenesisBiochemistry, 1997
- Alanine-scanning Mutagenesis of a Putative Substrate Recognition Site in Human Cytochrome P450 3A4Journal of Biological Chemistry, 1997
- Cooperativity in Oxidations Catalyzed by Cytochrome P450 3A4Biochemistry, 1997
- Structure and function of cytochromes P450:a comparative analysis of three crystal structuresStructure, 1995
- Activation of CYP3A4: Evidence for the Simultaneous Binding of Two Substrates in a Cytochrome P450 Active SiteBiochemistry, 1994